Characterization of neuronal dystrophy induced by fibrillar amyloid β: Implications for Alzheimer's disease

Neuroscience

Volumn 114, Issue 1, 2002, Pages 265-273

  Grace, E A ^a   Rabiner, C A ^a   Busciglio, J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Amyloid plaques; Cell adhesion; Cortical cultures; Neuronal plasticity; Neurotoxicity; Synaptic density

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL ADHESION; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; IMMUNOREACTIVITY; NEUROAXONAL DYSTROPHY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DENDRITES; DOWN-REGULATION; FETUS; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEURAL PATHWAYS; NEURITES; NEUROFIBRILS; NEURONAL PLASTICITY; NEURONS; PROTEIN STRUCTURE, TERTIARY; RATS; SYNAPSES; SYNAPTOPHYSIN;

EID: 0037130570     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00241-5     Document Type: Article

References (51)

1. Aplin A.E., Howe A., Alahari S.K., Juliano R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50:1998;197-263.
2. Baumann K., Mandelkow E.M., Biernat J., Piwnica-Worms H., Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 336:1993;417-424.
3. Benzing W.C., Mufson E.J., Armstrong D.M. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present. Brain Res. 606:1993;10-18.
4. Berg M.M., Krafft G.A., Klein W.L. Rapid impact of beta-amyloid on paxillin in a neural cell line. J. Neurosci. Res. 50:1997;979-989.
5. Busciglio J., Gabuzda D.H., Matsudaira P., Yankner B.A. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA. 90:1993;2092-2096.
6. Busciglio J., Lorenzo A., Yankner B.A. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
7. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
8. Busciglio J., Lorenzo A., Yeh J., Yankner B.A. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron. 14:1995;879-888.
9. Cao X., Sudhof T.C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 293:2001;115-120.
10. Cotman C.W., Anderson A.J. The brain's microenvironment, early functional loss, and the conversion to Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;112-116.
11. Cotman C.W., Hailer N.P., Pfister K.K., Soltesz I., Schachner M. Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations? Prog. Neurobiol. 55:1998;659-669.
12. Flaherty D.B., Soria J.P., Tomasiewicz H.G., Wood J.G. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J. Neurosci. Res. 62:2000;463-472.
13. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359:2001;1-16.
14. Geddes J.W., Anderson K.J., Cotman C.W. Senile plaques as aberrant sprout-stimulating structures. Exp. Neurol. 94:1986;767-776.
15. Geula C., Wu C.K., Saroff D., Lorenzo A., Yuan M., Yankner B.A. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nature Med. 4:1998;827-831.
16. Ghiso J., Rostagno A., Gardella J.E., Liem L., Gorevic P.D., Frangione B. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem. J. 288:1992;1053-1059.
17. Grace E., Busciglio J. Focal adhesion proteins are involved in Aβ-induced neuronal dystrophy. Abstr. Soc. Neurosci. 26:2000;1786.
18. Haass C., Steiner H. Protofibrils, the unifying toxic molecule of neurodegenerative disorders? Nature Neurosci. 4:2001;859-860.
19. Holgado A., Ferreira A. Synapse formation proceeds independently of dendritic elongation in cultured hippocampal neurons. J. Neurobiol. 43:2000;121-131.
20. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
21. Hughes E., Burke R.M., Doig A.J. Inhibition of toxicity in the beta-amyloid peptide fragment beta-(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. J. Biol. Chem. 275:2000;25109-25115.
22. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973.
23. Ivins K.J., Bui E.T., Cotman C.W. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: evidence for neuritic apoptosis. Neurobiol. Dis. 5:1998;365-378.
24. Juliano R.L., Haskill S. Signal transduction from the extracellular matrix. J. Cell Biol. 120:1993;577-585.
25. Koo E.H., Park L., Selkoe D.J. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. USA. 90:1993;4748-4752.
26. Li B.S., Zhang L., Gu J., Amin N.D., Pant H.C. Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 20:2000;6055-6062.
27. Lorenzo A., Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
28. Lorenzo A., Yuan M., Zhang Z., Paganetti P.A., Sturchler-Pierrat C., Staufenbiel M., Mautino J., Vigo F.S., Sommer B., Yankner B.A. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nature Neurosci. 3:2000;460-464.
29. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W. Jr., Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 56:2001;127-129.
30. Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R., Terry R., Baudier J., Saitoh T. Patterns of aberrant sprouting in Alzheimer's disease. Neuron. 6:1991;729-739.
31. Masliah E., Terry R.D., Alford M., DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38:1990;837-844.
32. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
33. Mattson M.P., Duan W. 'Apoptotic' biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J. Neurosci. Res. 58:1999;152-166.
34. Mattson M.P., Partin J., Begley J.G. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807:1998;167-176.
35. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron. 24:1999;521-529.
36. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20:2000;4050-4058.
37. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., Cowburn R.F. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res. 797:1998;267-277.
38. Phinney A.L., Deller T., Stalder M., Calhoun M.E., Frotscher M., Sommer B., Staufenbiel M., Jucker M. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 19:1999;8552-8559.
39. Pigino G., Pelsman A., Mori H., Busciglio J. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J. Neurosci. 21:2001;834-842.
40. Pike C.J., Cummings B.J., Cotman C.W. beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. NeuroReport. 3:1992;769-772.
41. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:1991;367-368.
42. Sabo S., Lambert M.P., Kessey K., Wade W., Krafft G., Klein W.L. Interaction of beta-amyloid peptides with integrins in a human nerve cell line. Neurosci. Lett. 184:1995;25-28.
43. Saporito-Irwin S.M., Van Nostrand W.E. Coagulation factor XIa cleaves the RHDS sequence and abolishes the cell adhesive properties of the amyloid beta-protein. J. Biol. Chem. 270:1995;26265-26269.
44. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
45. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
46. Small D.H. The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? Neurochem. Res. 23:1998;795-806.
47. Takahashi M., Iseki E., Kosaka K. Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary tangles-bearing neurons in Alzheimer type dementia brains. J. Neurol. Sci. 172:2000;63-69.
48. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C.A., Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. 92:1996;232-241.
49. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
50. Zhang C., Lambert M.P., Bunch C., Barber K., Wade W.S., Krafft G.A., Klein W.L. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. J. Biol. Chem. 269:1994;25247-25250.
51. Zhang C., Qiu H.E., Krafft G.A., Klein W.L. A beta peptide enhances focal adhesion kinase/Fyn association in a rat CNS nerve cell line. Neurosci. Lett. 211:1996;187-190.